Antibody Discovery Services
Revolutionise your research with our VHH antibody discovery services.
Start your discovery with us
Isogenica’s solutions are designed to maximise the overall success of your drug development projects by providing the right solutions with significantly reduced timelines, mitigated risks, and enhanced IP protection. This strategic investment ensures that our partners achieve not just short-term milestones but long-term commercial success.
VHH Antibody Discovery
- VHH antibody discovery from the world’s largest libraries
- Antigen biotinylation and QC
- CIS and phage display selections
- High throughput primary screening
Custom Assay Development
- Positive control setup
- Tailored primary screening and vector design
- Functional assays (antagonism, internalisation, cell killing)
- Primary cell assays
VHH Characterisation
- High-throughput expression
- Affinity measurement and epitope binning
- Biophysical analysis
- Binding analyses (specificity, cross-reactivity)
VHH Antibody Engineering
- Rapid bi-specific building and assessment
- Humanisation of synthetic or immune-derived VHHs
- Affinity maturation
- Tags and payload handles (e.g. sortase, free-cysteine)
Work with us
By partnering with our expert team, you’ll not only benefit from access to our state-of-the-art technology and expertise but also the perks of how we like to work with others. From start to finish we become an extended part of your team, keeping you updated and informed regularly on our progress. With our groundbreaking technology and expert guidance, Isogenica helps small to mid-sized biotech companies bring novel therapies to market faster— cutting typical discovery timelines in half by accelerating lead selection and reducing follow-on engineering requirements. Talk to us today and find out how we can accelerate your VHH discovery project.